{"id":293,"date":"2014-03-03T10:45:38","date_gmt":"2014-03-03T08:45:38","guid":{"rendered":"https:\/\/mic-site.labiux.com\/uncategorized\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/"},"modified":"2026-10-06T06:29:23","modified_gmt":"2026-10-06T03:29:23","slug":"grindeks-apgrozijums-un-pelna-palielinajusies-par-1","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/","title":{"rendered":"&#8220;Grindeks&#8221; apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1%"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>Latvijas z\u0101\u013cu ra\u017eot\u0101ja &#8220;Grindeks&#8221; koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji.<\/p>\n<p>Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tessabiedr\u012bbas akcion\u0101riem, 2013.gad\u0101 bijusi 13,8 miljoni eiro, kas, sal\u012bdzinot ar 2012.gadu, ir palielin\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\u013c\u0146as rentabilit\u0101te 2013.gad\u0101 bijusi 60%, savuk\u0101rt t\u012br\u0101s pe\u013c\u0146as rentabilit\u0101te &#8211; 11,6%. 2013.gad\u0101 koncerna sara\u017eot\u0101 produkcija eksport\u0113ta uz 59 pasaules valst\u012bm kopum\u0101 par 112,4 miljoniem eiro, kas ir par 1,2 miljoniem eiro jeb 1,1% vair\u0101k nek\u0101 2012.gad\u0101.<\/p>\n<p>&#8220;Grindeks&#8221; gatavo z\u0101\u013cu apgroz\u012bjums p\u0113rn bijis 100,3 miljoni eiro un, sal\u012bdzinot ar iepriek\u0161\u0113jo gadu, ir pieaudzis par 800 000 eiro jeb 1%. P\u0101rdo\u0161anas apjoms Krievija\u0101, p\u0101r\u0113j\u0101s NVS valst\u012bs un Gruzij\u0101 2013.gad\u0101 sasniedzis 86,7 miljonus eiro, savuk\u0101rt Baltijas un cit\u0101s Eiropas valst\u012bs &#8211; 13,6 miljonus eiro, kas ir par 100 000 eiro jeb 0,4% maz\u0101k nek\u0101 2012.gad\u0101.<\/p>\n<p>Piepras\u012bt\u0101kie medikamenti 2013.gad\u0101 biju\u0161i ori\u0123in\u0101lprodukts &#8220;Mildron\u0101ts&#8221;, ziedes &#8220;Capsicam&#8221;, &#8220;Viprosal B&#8221;, centr\u0101lo nervu sist\u0113mu ietekm\u0113jo\u0161\u0101s z\u0101les &#8220;Somnols&#8221;, ori\u0123in\u0101l\u0101s pretv\u0113\u017ea z\u0101les &#8220;Ftorafur&#8221; un dabas produkts &#8220;Apilak-Grindeks&#8221;.<\/p>\n<p>2013.gad\u0101 akt\u012bvo farmaceitisko vielu p\u0101rdo\u0161anas apjoms sasniedzis 18 miljonus eiro, kas ir par 100 000 eiro jeb 0,4% maz\u0101k nek\u0101 2012.gad\u0101. Kop\u0101 &#8220;Grindeks&#8221; ra\u017eo 25 akt\u012bv\u0101s farmaceitisk\u0101s vielas.<\/p>\n<p>Uz\u0146\u0113muma valdes priek\u0161s\u0113d\u0113t\u0101js Juris Bundulis presei izplat\u012bt\u0101 pazi\u0146ojum\u0101 nor\u0101da, ka finan\u0161u sasniegumi ir iev\u0113rojami, \u0146emot v\u0113r\u0101 s\u012bvo konkurenci farm\u0101cijas tirg\u016b. \u0160ogad&#8221;Grindeks&#8221; esot iecer\u0113jis pilnveidot savu darb\u012bbas modeli un aizvien vair\u0101k uzman\u012bbu koncentr\u0113t uz pla\u0161\u0101ku produktu un pakalpojumu kl\u0101stu. K\u0101 skaidro J.Bundulis, uz\u0146\u0113mumam ir pla\u0161s p\u0101rst\u0101vniec\u012bbu t\u012bkls, t\u0101p\u0113c tas turpin\u0101s piel\u0101goties katra re\u0123iona specifiskaj\u0101m vajadz\u012bb\u0101m. Vi\u0146\u0161 ir p\u0101rliecin\u0101ts, ka \u0161\u012bs ieceres palielin\u0101s uz\u0146\u0113muma darb\u012bbas efektivit\u0101ti.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Latvijas z\u0101\u013cu ra\u017eot\u0101ja &#8220;Grindeks&#8221; koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":216,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[70,76,7],"tags":[109],"mic_flag":[],"class_list":["post-293","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farmacijas-zinas","category-jaunakie-raksti","category-statistika","tag-grindeks"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Latvijas z\u0101\u013cu ra\u017eot\u0101ja &quot;Grindeks&quot; koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tessabiedr\u012bbas akcion\u0101riem, 2013.gad\u0101 bijusi 13,8 miljoni eiro, kas, sal\u012bdzinot ar 2012.gadu, ir palielin\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\u013c\u0146as rentabilit\u0101te 2013.gad\u0101 bijusi\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"\u201cGrindeks\u201d apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1% - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Latvijas z\u0101\u013cu ra\u017eot\u0101ja &quot;Grindeks&quot; koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tessabiedr\u012bbas akcion\u0101riem, 2013.gad\u0101 bijusi 13,8 miljoni eiro, kas, sal\u012bdzinot ar 2012.gadu, ir palielin\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\u013c\u0146as rentabilit\u0101te 2013.gad\u0101 bijusi\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/Grindex.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/Grindex.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"140\" \/>\n\t\t<meta property=\"og:image:height\" content=\"41\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-03-03T08:45:38+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-06T03:29:23+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"\u201cGrindeks\u201d apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1% - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Latvijas z\u0101\u013cu ra\u017eot\u0101ja &quot;Grindeks&quot; koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tessabiedr\u012bbas akcion\u0101riem, 2013.gad\u0101 bijusi 13,8 miljoni eiro, kas, sal\u012bdzinot ar 2012.gadu, ir palielin\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\u013c\u0146as rentabilit\u0101te 2013.gad\u0101 bijusi\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/Grindex.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"position\":2,\"name\":\"Statistika\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#listItem\",\"name\":\"&#8220;Grindeks&#8221; apgroz\\u012bjums un pe\\u013c\\u0146a palielin\\u0101ju\\u0161ies par 1%\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#listItem\",\"position\":3,\"name\":\"&#8220;Grindeks&#8221; apgroz\\u012bjums un pe\\u013c\\u0146a palielin\\u0101ju\\u0161ies par 1%\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/statistika\\\/#listItem\",\"name\":\"Statistika\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#newsarticle\",\"name\":\"\\u201cGrindeks\\u201d apgroz\\u012bjums un pe\\u013c\\u0146a palielin\\u0101ju\\u0161ies par 1% - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"&#8220;Grindeks&#8221; apgroz\\u012bjums un pe\\u013c\\u0146a palielin\\u0101ju\\u0161ies par 1%\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/Grindex.jpg\",\"width\":140,\"height\":41},\"datePublished\":\"2014-03-03T10:45:38+02:00\",\"dateModified\":\"2026-10-06T06:29:23+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#webpage\"},\"articleSection\":\"Farm\\u0101cija, Jaun\\u0101kie raksti, Statistika, Grindeks\",\"dateline\":\"Published on March 3, 2014.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/\",\"name\":\"\\u201cGrindeks\\u201d apgroz\\u012bjums un pe\\u013c\\u0146a palielin\\u0101ju\\u0161ies par 1% - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Latvijas z\\u0101\\u013cu ra\\u017eot\\u0101ja \\\"Grindeks\\\" koncerna apgroz\\u012bjums p\\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\\u0101k nek\\u0101 2012.gad\\u0101, zi\\u0146o uz\\u0146\\u0113muma p\\u0101rst\\u0101vji. Koncerna neto pe\\u013c\\u0146a, kas attiecin\\u0101ma uz m\\u0101tessabiedr\\u012bbas akcion\\u0101riem, 2013.gad\\u0101 bijusi 13,8 miljoni eiro, kas, sal\\u012bdzinot ar 2012.gadu, ir palielin\\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\\u013c\\u0146as rentabilit\\u0101te 2013.gad\\u0101 bijusi\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/Grindex.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#mainImage\",\"width\":140,\"height\":41},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\\\/#mainImage\"},\"datePublished\":\"2014-03-03T10:45:38+02:00\",\"dateModified\":\"2026-10-06T06:29:23+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"\u201cGrindeks\u201d apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1% - Medikamentu Inform\u0101cijas Centrs","description":"Latvijas z\u0101\u013cu ra\u017eot\u0101ja \"Grindeks\" koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tessabiedr\u012bbas akcion\u0101riem, 2013.gad\u0101 bijusi 13,8 miljoni eiro, kas, sal\u012bdzinot ar 2012.gadu, ir palielin\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\u013c\u0146as rentabilit\u0101te 2013.gad\u0101 bijusi","canonical_url":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","position":2,"name":"Statistika","item":"https:\/\/farmacija-mic.lv\/category\/statistika\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#listItem","name":"&#8220;Grindeks&#8221; apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1%"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#listItem","position":3,"name":"&#8220;Grindeks&#8221; apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1%","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/statistika\/#listItem","name":"Statistika"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#newsarticle","name":"\u201cGrindeks\u201d apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1% - Medikamentu Inform\u0101cijas Centrs","headline":"&#8220;Grindeks&#8221; apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1%","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/Grindex.jpg","width":140,"height":41},"datePublished":"2014-03-03T10:45:38+02:00","dateModified":"2026-10-06T06:29:23+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#webpage"},"articleSection":"Farm\u0101cija, Jaun\u0101kie raksti, Statistika, Grindeks","dateline":"Published on March 3, 2014."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/","name":"\u201cGrindeks\u201d apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1% - Medikamentu Inform\u0101cijas Centrs","description":"Latvijas z\u0101\u013cu ra\u017eot\u0101ja \"Grindeks\" koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tessabiedr\u012bbas akcion\u0101riem, 2013.gad\u0101 bijusi 13,8 miljoni eiro, kas, sal\u012bdzinot ar 2012.gadu, ir palielin\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\u013c\u0146as rentabilit\u0101te 2013.gad\u0101 bijusi","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/Grindex.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#mainImage","width":140,"height":41},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/#mainImage"},"datePublished":"2014-03-03T10:45:38+02:00","dateModified":"2026-10-06T06:29:23+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"\u201cGrindeks\u201d apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1% - Medikamentu Inform\u0101cijas Centrs","og:description":"Latvijas z\u0101\u013cu ra\u017eot\u0101ja &quot;Grindeks&quot; koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tessabiedr\u012bbas akcion\u0101riem, 2013.gad\u0101 bijusi 13,8 miljoni eiro, kas, sal\u012bdzinot ar 2012.gadu, ir palielin\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\u013c\u0146as rentabilit\u0101te 2013.gad\u0101 bijusi","og:url":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/Grindex.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/Grindex.jpg","og:image:width":140,"og:image:height":41,"article:published_time":"2014-03-03T08:45:38+00:00","article:modified_time":"2026-10-06T03:29:23+00:00","twitter:card":"summary_large_image","twitter:title":"\u201cGrindeks\u201d apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1% - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Latvijas z\u0101\u013cu ra\u017eot\u0101ja &quot;Grindeks&quot; koncerna apgroz\u012bjums p\u0113rn bijis 118,5 miljoni eiro, kas ir par 800 000 eiro jeb 1% vair\u0101k nek\u0101 2012.gad\u0101, zi\u0146o uz\u0146\u0113muma p\u0101rst\u0101vji. Koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tessabiedr\u012bbas akcion\u0101riem, 2013.gad\u0101 bijusi 13,8 miljoni eiro, kas, sal\u012bdzinot ar 2012.gadu, ir palielin\u0101jusies par 100 000 eiro jeb 1%. Bruto pe\u013c\u0146as rentabilit\u0101te 2013.gad\u0101 bijusi","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/Grindex.jpg"},"aioseo_meta_data":{"post_id":"293","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-09-22 18:24:32","updated":"2026-10-07 11:00:08"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/statistika\/\" title=\"Statistika\">Statistika<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t\u201cGrindeks\u201d apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1%\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Statistika","link":"https:\/\/farmacija-mic.lv\/category\/statistika\/"},{"label":"&#8220;Grindeks&#8221; apgroz\u012bjums un pe\u013c\u0146a palielin\u0101ju\u0161ies par 1%","link":"https:\/\/farmacija-mic.lv\/en\/grindeks-apgrozijums-un-pelna-palielinajusies-par-1\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=293"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/293\/revisions"}],"predecessor-version":[{"id":2025,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/293\/revisions\/2025"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/216"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=293"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}